Less than one in four adolescent men who have sex with men (AMSM) ever get tested for HIV, research funded by NIMHD has reported. The researchers recruited 699 AMSM participants, ages 13-18 years, from an ongoing trial, called SMART, that is evaluating existing HIV prevention programs.

A little-known ocean-dwelling creature most commonly found growing on dead hermit crab shells may sound like an unlikely study subject for researchers, but this animal has a rare ability—it can make eggs and sperm for the duration of its lifetime.

The first of 5 early stage clinical trials to test the safety and ability of an investigational Zika vaccine candidate called the Zika purified inactivated virus (ZPIV) vaccine has begun at Walter Reed Army Institute of Research.

Researchers at NCATS, the Clinical Center and NIAID have created a new way to identify drugs and drug combinations that may potentially be useful in combating infections that are resistant to many different antibiotics.

Big data derived from electronic health records, social media, the Internet and other digital sources have the potential to provide more timely and detailed information on infectious disease threats or outbreaks than traditional surveillance methods.

In a range of experiments, scientists have reactivated resting immune cells that were latently infected with HIV or its monkey relative, SIV, in cells in the bloodstream and a variety of tissues in animals. As a result, the cells started making copies of the viruses, which could potentially be neutralized by anti-HIV drugs and the immune system.

Children as young as 6 years old who underwent fetal surgery to repair a common birth defect of the spine are more likely to walk independently and have fewer follow-up surgeries, compared to those who had traditional corrective surgery after birth, according to researchers funded by NIH.

Homicide is a leading cause of death among pregnant and postpartum women in Louisiana, according to an analysis of birth and death records from 2016 and 2017.

A phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the Clinical Center.

Scientists report that endocannabinoids, natural messengers in the body that are chemically similar to the active compound in marijuana, play an important role in how the brain controls this fundamental process.